The Impact of the human endogenous metabolome on drug pharmacology and safety
A great deal of efforts has been made to improve and expand pharmacological testing and optimisation of drug candidates during the discovery process. However, we are yet to understand fully why drugs require certain levels of affinity for their mechanism of action targets to exert their therapeutic...
| Autor: | |
|---|---|
| Tipo de recurso: | tesis doctoral |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | CBUC, CESCA |
| Repositorio: | TDR. Tesis Doctorales en Red |
| OAI Identifier: | oai:www.tdx.cat:10803/671531 |
| Acceso en línea: | http://hdl.handle.net/10803/671531 |
| Access Level: | acceso abierto |
| Palabra clave: | Endogenous metabolome Drug efficacy Polypharmacology Drug safety Personalized medicine Metaboloma endogen Eficàcia dels fàrmacs Polifarmacologia Seguretat dels fàrmacs Medicina personalitzada 615 |
| Sumario: | A great deal of efforts has been made to improve and expand pharmacological testing and optimisation of drug candidates during the discovery process. However, we are yet to understand fully why drugs require certain levels of affinity for their mechanism of action targets to exert their therapeutic effect. In parallel, the mechanistic understanding of the endogenous metabolome has been demonstrated to have incredible implications in drug discovery, being potentially one of the pillars of precision medicine. Endogenous metabolites are small molecules evolutionally optimised to interact in an appropriate way with its native protein with a specific level of affinity. This Thesis provides evidences that the level of affinity required by a drug to interact with its primary target and produce a therapeutic effect is related to the affinity of the native endogenous metabolite for that target. In addition, this Thesis also highlights the implications that the human endogenous metabolome could have to assess a more realistic drug polypharmacology landscape and the risk of safety events linked to it. Finally, an analysis of natural compound pharmacology on the perspective of the endogenous metabolome is also performed. All results indicate that understanding the role of the human metabolome and its implications on drug bioactivity could offer a new useful perspective in drug efficacy and safety |
|---|